Charles Schwab Investment Management Inc Pds Biotechnology Corp Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 77,203 shares of PDSB stock, worth $226,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,203
Previous 77,203
-0.0%
Holding current value
$226,204
Previous $383,000
20.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PDSB
# of Institutions
76Shares Held
7.53MCall Options Held
140KPut Options Held
318K-
Black Rock Inc. New York, NY1.87MShares$5.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$4.65 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA654KShares$1.92 Million0.0% of portfolio
-
State Street Corp Boston, MA557KShares$1.63 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC355KShares$1.04 Million0.23% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $83.4M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...